A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies. (Q34617336)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies. |
scientific article |
Statements
A phase I pharmacologic study of necitumumab (IMC-11F8), a fully human IgG1 monoclonal antibody directed against EGFR in patients with advanced solid malignancies (English)
Bart Kuenen
Petronella O Witteveen
Rita Ruijter
Aruna Dontabhaktuni
Floyd Fox
Terry Katz
Hagop Youssoufian
Junming Zhu
Eric K Rowinsky